Acetylated HOXB13 Regulated Super Enhancer Genes Define Therapeutic Vulnerabilities of Castration-Resistant Prostate Cancer

Using primary human prostate organoids, the authors evaluated whether inhibiting an acK13-HOXB13 target, ACK1, with a selective inhibitor (R)-9b was superior to androgen receptor antagonists in inhibiting castration-resistant prostate cancer growth.